HYAL2 and central nervous system cancer: To elucidate the feasibility of HYAL2 serving as an independent risk factor for glioma prognosis, the univariate Cox analysis demonstrated that HYAL2 expression levels were negatively associated with glioma prognosis in the TCGA database (HR = 2.527, P < 0.001) (Fig. 3A).